BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1646295)

  • 1. (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens.
    Longoni R; Spina L; Mulas A; Carboni E; Garau L; Melchiorri P; Di Chiara G
    J Neurosci; 1991 Jun; 11(6):1565-76. PubMed ID: 1646295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive and behavioral effects of synthetic deltorphin analogs.
    Negri L; Noviello L; Noviello V
    Eur J Pharmacol; 1996 Jan; 296(1):9-16. PubMed ID: 8720471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural effects of deltorphins in rats.
    Negri L; Noviello V; Angelucci F
    Eur J Pharmacol; 1991 Dec; 209(3):163-8. PubMed ID: 1665794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release.
    Acquas E; Meloni M; Di Chiara G
    Eur J Pharmacol; 1993 Jan; 230(2):239-41. PubMed ID: 8380771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
    Izenwasser S; Búzás B; Cox BM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-induced stimulation of fetal respiratory activity by [D-Ala2]deltorphin I.
    Cheng PY; Wu D; Decena J; Soong Y; McCabe S; Szeto HH
    Eur J Pharmacol; 1993 Jan; 230(1):85-8. PubMed ID: 8381356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms.
    Murakawa K; Hirose N; Takada K; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Eur J Pharmacol; 2004 Apr; 491(1):31-6. PubMed ID: 15102530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothermic effect of D-Ala-deltorphin II, a selective delta opioid receptor agonist.
    Broccardo M; Improta G
    Neurosci Lett; 1992 May; 139(2):209-12. PubMed ID: 1319015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
    Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
    Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of antisense oligodeoxynucleotide to determine delta-opioid receptor involvement in [D-Ala2]deltorphin II-induced locomotor hyperactivity.
    Mizoguchi H; Narita M; Nagase H; Suzuki T; Quock RM; Tseng LF
    Life Sci; 1996; 59(4):PL69-73. PubMed ID: 8761010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats.
    Matsuzaki S; Ikeda H; Akiyama G; Sato M; Moribe S; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuropharmacology; 2004 Jun; 46(8):1089-96. PubMed ID: 15111015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.
    Di Chiara G; Imperato A
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1067-80. PubMed ID: 2855239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.
    Daugé V; Rossignol P; Roques BP
    Psychopharmacology (Berl); 1989; 99(2):168-75. PubMed ID: 2572028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
    Qi JA; Mosberg HI; Porreca F
    Life Sci; 1990; 47(11):PL43-7. PubMed ID: 2170791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
    Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
    Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
    Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
    Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta opioid receptors mediate seizures produced by intrahippocampal injection of ala-deltorphin in rats.
    De Sarro GB; Marra R; Spagnolo C; Nisticò G
    Funct Neurol; 1992; 7(3):235-8. PubMed ID: 1323508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding in vivo of selective mu and delta opioid agonists: localization by autoradiography.
    Mokhtari M; Tafani JA; Zajac JM
    Neuropeptides; 1993 Sep; 25(3):183-91. PubMed ID: 8247256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.